NCT00791856View on ClinicalTrials.gov

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

testosterone

28 cm2 testosterone patch, each patch is on for 4 days, 3 patches are used

DRUG

testosterone

14 cm2 testosterone patch, each patch is on for 4 days, 3 patches are used

Trial Locations (4)

33025

Maria J Gulierrez, MD, Miramar

33901

Antonio Pizarro, MD, Fort Myers

66211

David R Mathews, MD, Overland Park

68154

Robert J Schwab, MD, Omaha

Sponsors

Lead Sponsor

Warner Chilcott
All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00791856 - Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch | Biotech Hunter | Biotech Hunter